Adenoid Hypertrophy

What is adenoid hypertrophy?

Adenoid hypertrophy refers to the pathological enlargement of the pharyngeal tonsil within the roof and posterior wall of the nasopharynx, which can narrow the choanae and impair nasal airflow. This lymphoid tissue commonly enlarges after repeated mucosal antigen exposure, most often affecting children aged two to six years. Persistence or new-onset hypertrophy beyond childhood is uncommon and warrants further evaluation. The condition remains one of the leading causes of chronic nasal obstruction and contributes to sleep-disordered breathing, making early recognition critical for avoiding long-term craniofacial remodeling and otologic sequelae.

What causes adenoid hypertrophy?

Chronic immune stimulation triggers adenoid hypertrophy through lymphoid hyperplasia and increased interstitial fluid within the Waldeyer ring, often in the setting of adenotonsillar hypertrophy driven by recurrent upper respiratory infections and allergic inflammation. Viral illnesses and bacterial colonization promote cytokine release that enhances lymphoid proliferation, while environmental irritants such as passive smoke exposure and air pollution heighten mucosal immune responses. Anatomical factors, including narrow nasal passages or craniofacial anomalies, worsen obstruction and perpetuate a cycle of mouth breathing that further reduces nasopharyngeal clearance, maintaining the hypertrophic state.

What are the signs and symptoms of adenoid hypertrophy?

Adenoid hypertrophy commonly presents with persistent nasal obstruction, snoring, and mouth breathing, as airflow is diverted through the mouth due to obstruction of the posterior choanae. Children often develop adenoid facies, characterized by an open mouth, elongated face, and flattened nasal bridge, resulting from chronic oral breathing and altered muscle tone. Noisy breathing during sleep, frequent upper airway infections, and otitis media with effusion emerge as associated findings. Chronic hypoventilation may be associated with behavioral changes, such as irritability or attention deficits. Coexistent adenotonsillar hypertrophy often amplifies symptoms, and the combination may progress to obstructive sleep apnea, warranting early evaluation.

How is the cause of adenoid hypertrophy diagnosed?

Clinicians suspect adenoid hypertrophy when nasal obstruction persists despite typical treatments and is accompanied by characteristic facies or middle ear effusion. Anterior rhinoscopy may reveal a bulging choanal curtain, while nasopharyngoscopy confirms the extent of the hypertrophic adenoid mass. When endoscopy is unavailable, lateral neck radiographs may be used to estimate adenoid size, while tympanometry assesses middle ear pressure to detect effusions related to Eustachian tube obstruction. Sleep studies become imperative if obstructive sleep apnea is suspected, allowing correlation between airway narrowing and nocturnal oxygen desaturation. This stepwise approach helps confirm the diagnosis and guide appropriate therapy.

How is adenoid hypertrophy treated?

Initial management of adenoid hypertrophy includes medical therapy: intranasal corticosteroids aim to reduce lymphoid tissue volume, saline irrigations improve mucosal clearance, and antibiotics address bacterial superinfection when present. For persistent obstruction, recurrent otitis media, or sleep-disordered breathing, surgical adenotonsillar hypertrophy management through adenoidectomy—often combined with tonsillectomy—is indicated, with careful preoperative evaluation of bleeding risk and comorbidities. Postoperative care includes analgesia, hydration, and monitoring for nasal bleeding or velopharyngeal insufficiency, along with ongoing surveillance of nasal patency and middle ear function.

What are the most important facts to know about Adenoid Hypertrophy?

• Adenoid Hypertrophy refers to pathological enlargement of the pharyngeal tonsil that narrows the choanae and impairs nasal airflow, most commonly in children aged two to six years.
• Chronic immune stimulation from recurrent infections or allergic inflammation drives the lymphoid hyperplasia.
• Hallmark features include persistent nasal obstruction, mouth breathing, snoring, and recurrent ear infections; untreated cases may progress to obstructive sleep apnea.
• Diagnosis relies on clinical suspicion supported mainly by nasopharyngoscopy; imaging is used when necessary, and tympanometry serves to assess middle ear involvement.
• Initial treatment involves intranasal corticosteroids; adenoidectomy is indicated for persistent obstruction, recurrent infections, or sleep-disordered breathing.
• Early recognition and management reduce the risk of long-term craniofacial changes, hearing impairment, and neurocognitive effects related to chronic hypoventilation.